Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Wave Life Sciences Ltd.

www.wavelifesciences.com

Latest From Wave Life Sciences Ltd.

US FDA's Complex Trial Design Pilot May Change 'Ambitious' Timelines

Program allows eight months for sponsors to be accepted and conduct two meetings with FDA on an innovative design, but the agency said more time may be needed.
Clinical Trials Research and Development Strategies

Finance Watch: Gossamer Works Around The Shutdown To Price Its $230m IPO

Gossamer took an infrequently used path to go public during a US government shutdown that's kept the SEC from processing new offerings. Also, IPO filings (and withdrawals) and follow-on offerings continued during the shutdown, while VC deals keep up a brisk pace.

Financing Business Strategies

Scrip Asks... What Will 2019 Hold For Biopharma? Part 1: Therapeutic Advances

Scrip journalists asked industry executives, consultants and analysts what they believe the big themes, trends and events will be in 2019. Here's what they told us about advances in therapeutic technologies and areas of clinical innovation.

Innovation Market Intelligence

Laquinimod Disappoints Again, This Time In Huntington's Disease

Laquinimod fails to impress in a Phase II study in Huntington's disease, adding to a series of clinical trial setbacks over past years for the potential oral immunomodulator.

 

Clinical Trials Neurology
See All

Company Information

  • Industry
  • Biotechnology
    • Antisense, Oligonucleotides
    • Drug Discovery Tools
    • Gene Therapy, Cell Therapy
    • Large Molecule
  • Pharmaceuticals
  • Therapeutic Areas
  • Dermatology
  • Gastrointestinal
  • Musculoskeletal & Connective Tissue Disorders
  • Neurology, Nervous System
  • Alias(es)
  • Ontorii Pharmaceuticals
  • Chiralgen
  • Wave Life Sciences Pte. Ltd.
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Wave Life Sciences Ltd.
  • Senior Management
  • Paul Bolno, MD, Pres. & CEO
    Keith Regnante, CFO
    Chris Francis, PhD, SVP, Corp. Dev.
    Chandra Vargeese, PhD, SVP, Drug Discovery
    Michael Panzara, MD, CMO
    Mark Baldry, Chief Commercial Officer
  • Contact Info
  • Wave Life Sciences Ltd.
    Phone: (617) 949-2900
    733 Concord Ave.
    Cambridge, MA 02138
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register